NeuroCharge combines HRV and EDA biometric capture to provide clinicians with objective physiological data at the triage stage — deployable at community pharmacy level, complementing NICE NG87.
Current triage relies entirely on subjective self-report. No physiological data. No objective signal. Clinicians are making prioritisation decisions without the tools to do so accurately.
GP-referred or self-referred patient places palm flat on the NeuroCharge pad. No specialist training required. No appointment needed.
HRV captured via MAX30102 optical sensor. EDA captured via gold cup electrodes at thenar and hypothenar pads. Short-duration static capture. Non-invasive. Optimal duration to be determined through feasibility study.
Physiological data uploads to a remote clinician dashboard. Reviewed asynchronously. Highest-risk patients prioritised. ~20 minutes of clinician time saved per patient.
v0.1 DRAFT · DCB0129 aligned
8 hazards documented · DCB0129 aligned
MAUDE review completed 5 April 2026
ZB655593 · UK GDPR compliant
Appointment pending · Required before feasibility study
NeuroCharge is designed from the ground up for the UK regulatory pathway. Every design decision — from sensor selection to data architecture — is made with MHRA Class IIa requirements in mind.
ISO 13485 QMS framework in progress. IEC 60601-1 electrical safety standards — target compliance. HRA ethical approval process to be initiated before any clinical feasibility study.
Each product addresses a different moment in the neurodivergent experience — from diagnosis to daily functioning.
Non-invasive HRV + EDA physiological triage device for NHS ADHD assessment pathways. Pharmacy-deployable. MHRA Class IIa target.
Autonomous AI agent — a Prosthetic Prefrontal Cortex. Monitors executive function and acts on behalf of the user when they can't. First paying customer secured.
Therapeutic wearable for freeze-state intervention. Bilateral haptic stimulation at the vagus nerve. 40Hz gamma entrainment + 0.1Hz vagal breath-pacing.
Self-advocacy toolkit for late-diagnosed neurodivergent adults. Accommodation passports, AI advocacy letters, and workplace rights navigation.
We are engaging clinicians, NHS partners, and strategic advisors. If you're working in ADHD assessment, community pharmacy, or health innovation — we'd like to hear from you.